MetLife Valuation Overview

MET -- USA Stock  

USD 45.66  0.05  0.11%

MetLife secures last-minute Real Value of $51.0075 per share. The latest price of the firm is $45.66. At this time the firm appears to be under valued. Macroaxis forecasts value of MetLife from analyzing the firm fundamentals such as Current Valuation of 109.58B, Profit Margin of 7.07% and Return On Equity of 8.52% as well as examining its technical indicators and Probability Of Bankruptcy. In general, we recommend to purchase undervalued stocks and to get rid of overvalued stocks since at some point entities prices and their ongoing real values will merge together.

Valuation Drivers Correlation

Selected MetLife Valuation Data Over Time

Revenue Per Employee    Average Assets    Earnings Before Interest Taxes and Depreciation Amortization EBITDA    
 Time Horizon     30 Days    Login   to change
MetLife is regarded second in beta category among related companies. It is rated below average in price to earning category among related companies reporting about  11.64  of Price to Earning per Beta.

Current Market Valuation

MetLife Valuation Boundaries
Under Valued
June 24, 2018
45.66
Market Value
51.01
Real Value
Target Odds
  
55.66
Upside
MetLife is not too risky asset. Calculation of real value of MetLife is based on 1 month time horizon. Increasing MetLife time horizon generally increases accuracy of value calculation and significantly improves predictive power of the methodology used.

Tax Efficiency

MetLife Tax Efficiency History

Tax Efficiency

Market Capitalization

MetLife Market Capitalization Analysis
MetLife is regarded fourth in market capitalization category among related companies. Market capitalization of Insurance - General industry is now estimated at about 276.2 Billion. MetLife retains roughly 46.55 Billion in market capitalization claiming about 17% of equities under Insurance - General industry.
Capitalization  Total debt  Workforce  Valuation  Revenue
Please see also Stocks Correlation. Please also try Fundamental Analysis module to view fundamental data based on most recent published financial statements.